SEC Form 4 · accession 0001144204-16-120788
Moleculin Biotech, Inc. · MBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan P. Foster
Officer — Exec. Vice President & CFO
Period of report
Aug 19, 2016
Accepted (ET)
Aug 23, 2016 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659617
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF2,F1 | $5.85 | Aug 19, 2016 | A | 400,000 | A | — | Aug 19, 2026 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1The options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service as the Company's Chief Financial Officer.
- F2The options were issued in connection with the reporting person's employment service to the Company.